ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
THX Pharma

THX Pharma (ALTHX)

3,325
0,015
( 0,45% )
Aktualisiert: 09:43:24

THX Pharma (ALTHX) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
3,325
( 0,45% )
Gebot
3,31
Fragen
3,33
Volumen
4.828
3,285 Tagesbereich 3,325
0,982 52-Wochen-Bereich 5,10
Marktkapitalisierung
Handelsende
3,31
Handelsbeginn
3,285
Letzte Trade
500
@
3.325
Letzter Handelszeitpunkt
09:43:24
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
110.425 €
Ausgegebene Aktien
13.796.556
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-15,26
Gewinn pro Aktie (EPS)
-0,22
Erlöse (LTM)
806,05k
Nettogewinn (LTM)
-3M

Über THX Pharma

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The compan... THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Lyon, France
Gegründet
2026
THX Pharma is listed in the Healthcare sector of the Euronext with ticker ALTHX. The last closing price for THX Pharma was 3,31 €. Over the last year, THX Pharma shares have traded in a share price range of 0,982 € to 5,10 €.

THX Pharma currently has 13.796.556 shares in issue. The market capitalisation of THX Pharma is 45,87 € million. THX Pharma has a price to earnings ratio (PE ratio) of -15.26.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.1755.555555555563.153.4553.14409543.3293857DE
40.1554.889589905363.174.13.0551330993.62790591DE
120.216.741573033713.1154.13.0351162103.5266984DE
261.3971.8346253231.9355.11.831624423.33630552DE
522.325232.515.10.9821519962.8460383DE
1561.425751.95.10.2605725922.12038467DE
260-6.935-67.592592592610.2610.580.2605535912.48122344DE

ALTHX - Frequently Asked Questions (FAQ)

What is the current THX Pharma share price?
The current share price of THX Pharma is 3,325 €
How many THX Pharma shares are in issue?
THX Pharma has 13.796.556 shares in issue
What is the market cap of THX Pharma?
The market capitalisation of THX Pharma is EUR 45,87M
What is the 1 year trading range for THX Pharma share price?
THX Pharma has traded in the range of 0,982 € to 5,10 € during the past year
What is the PE ratio of THX Pharma?
The price to earnings ratio of THX Pharma is -15,26
What is the cash to sales ratio of THX Pharma?
The cash to sales ratio of THX Pharma is 56,83
What is the registered address of THX Pharma?
The registered address for THX Pharma is 60, Avenue Rockefeller, Lyon, Rhône-Alpes, 69008
What is the THX Pharma website address?
The website address for THX Pharma is www.theranexus.com
Which industry sector does THX Pharma operate in?
THX Pharma operates in the Biotechnology & Life Sciences sector

ALTHX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen